"Suboptimal" kidney donors: The experience with tacrolimus-based immunosuppression

Transplantation

Volumn 62, Issue 9, 1996, Pages 1242-1246

  Shapiro, Ron ^a,b   Vivas, Carlo ^c   Scantlebury, Velma P ^a   Jordan, Mark L ^c   Gritsch, H Albin ^c   Neugarten, Joel ^d   Mccauley, Jerry ^a   Randhawa, Parmjeet ^e   Irish, William ^a   Fung, John J ^a   Hakala, Thomas ^c   Simmons, Richard L ^e   Starzl, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Albert Einstein College of Medicine ^*  (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AZATHIOPRINE; CREATININE; NITROGEN; PREDNISONE; TACROLIMUS; UREA;

AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGE FACTORS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SEX FACTORS; TACROLIMUS; TISSUE DONORS;

EID: 0030478913     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199611150-00010     Document Type: Article

References (36)

1. Cecka JM, Terasaki PI. The UNOS Scientific Renal Transplant Registry. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1993. Los Angeles: UCLA Tissue Typing Laboratory, 1994: 1.
2. Takiff H. Donor factors. In: Terasaki PI, ed. Clinical transplants 1989. Los Angeles: UCLA Tissue Typing Laboratory, 1990: 417.
3. Shibue T, Kondo K, Iwaki Y, Terasaki PI. Effect of sex on kidney transplants. In: Terasaki PI, ed. Clinical transplants 1987. Los Angeles: UCLA Tissue Typing Laboratory, 1987: 351.
4. Kenneally P. The impact of sex on kidney transplantation. In: Terasaki PI, ed. Clinical kidney transplant 1985. Los Angeles: UCLA Tissue Typing Laboratory, 1985: 147.
5. Zhou YC, Cecka JM. Effect of sex on kidney transplants. In: Terasaki PI, ed. Clinical transplant 1989. Los Angeles: UCLA Tissue Typing Laboratory 1989: 361.
6. Koka P, Cecka JM. Sex and age effects in renal transplantation. In: Terasaki PI, ed. Clinical transplants 1990. Los Angeles: UCLA Tissue Tying Laboratory, 1990: 437.
7. Cecka JM. Donor factors. In: Terasaki PI, ed. Clinical transplants 1987. los Angeles: UCLA Tissue Typing Laboratory, 1987: 423.
8. Yuge J, Cecka JM. Sex and age effects in renal transplantation. In: Terasaki PI, ed. Clinical transplants 1991. Los Angeles: UCLA Tissue Typing Laboratory, 1991: 257.
9. Thorogood J, van Houwelingen JC, van Rood JJ, Zantvoom FA, Schreuder GMT, Persign GG. Factors contributing to long-term kidney graft survival in Eurotransplantation. Transplantation 1992; 54: 152.
10. Hong JH, Shirani K, Arshad A, et al. Influence of cadaver donor age on the success of kidney transplants. Transplantation 1981; 32: 532.
11. Ploeg RJ, Visser MJT, Stijnen T, Persijn GG, van Schilfgaarde R. Impact of donor age and quality of donor kidneys on graft survival. Transplant Proc 1987; 19: 1532.
12. Opelz G. Influence of recipient and donor age in pediatric renal transplantation. Transpl Int 1988; 1: 95.
13. Yuge J, Cecka JM. Pediatric recipients and donors. In: Terasaki PI, ed. Clinical transplants 1990. Los Angeles: UCLA Tissue Typing Laboratory, 1990: 425.
14. Alexander JW, Vaughn WK, Carey MA. The use of marginal donors for organ transplantation: the older and younger donors. Transplant Proc 1991; 23: 905.
15. Smith AY, van Buren CT, Lewis RM, Kerman RH, Kahan BD. Short-term and long-term function of cadaveric kidneys from pediatric donors in recipients treated with cyclosporine. Transplantation 1988; 45: 360.
16. Brenner BM, Milford EL. Nephron underdosing: a programmed cause of chronic renal allograft failure. Am J Kidney Dis 1993; 21 (suppl 2):66.
17. Brenner BM, Cohen RA, Milford EL. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992; 3: 162.
18. Shapiro R, Jordan M, Scantlebury V, et al. A prospective, randomized trial of FK506 in renal transplantation: a comparison between double and triple drug therapy. Clin Transplant 1994; 8: 509.
19. Shapiro R, Jordan ML, Scantlebury VP, et al. A prospective, randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation 1995; 59: 485.
20. Shapiro R, Jordan ML, Scantlebury VP, et al. A prospective, randomized trial of FK506/prednisone vs FK506/azathioprine/prednisone in renal transplant patients. Transplant Proc 1995; 27(1): 814.
21. Shapiro R, Scantlebury VP, Jordan ML, et al. FK506 in pediatric kidney transplantation - primary and rescue experience. Pediatr Nephrol 1995; 9 (suppl): S43.
22. Laskow DA, Vincenti F, Neylan J, Mendez R, Matas A. Phase II FK506 Multicenter Concentration Control Study: one-year follow-up. Transplant Proc 1995; 22(1): 809.
23. Gjertson DW, Cecka JM, Terasaki PI. The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation 1995; 60(12): 1384.
24. UNOS Update. 1995; 11(12): 26.
25. UNOS Update. 1994; 10(12): 27.
26. Neugarten J, Silbiger SR. The impact of gender on renal transplantation. Transplantation 1994; 58(11): 1145.
27. McCauley J, Takaya S, Fung J, et al. The question of FK506 nephrotoxicity after liver transplantation. Transplant Proc 1991; 23(1): 1444.
28. Starzl TE, Abu-Elmagd K, Tzakis A, et al. Selected topics on FK506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc 1991; 23(1): 914.
29. Starzl TE. FK506 versus cyclosporine. Transplant Proc 1993; 25(1): 511.
30. Demetris AJ, Banner B, Fung JJ, et al. Histopathology of human renal allograft function under FK506: a comparison with cyclosporine. Transplant Proc 1991; 23: 944.
31. Randhawa PS, Shapiro R, Jordan ML, Starzl TE, Demetris AJ. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506: clinical significance and comparison with cyclosporine. Am J Surg Pathol 1993; 17(1): 60.
32. Nghiem DD, Hsia S, Schlosser JD. Growth and function of en bloc infant kidney transplant: a preliminary study. J Urol 1995; 153(2): 326.
33. Darras F, Jordan ML, Shapiro R, et al. Transplantation of pediatric en bloc kidneys under FK 506 immunosuppression. Transplant Proc 1991; 23: 3089.
34. Gruessner RWG, Matas AJ, Lloveras G. A comparison of single and double pediatric cadaver donor kidneys for transplantation. Clin Transplant 1989; 3: 209.
35. Vivas CA, O'Donovan RM, Jordan ML, et al. Cadaveric renal transplantation using kidneys from donors greater than 60 years old. Clin Transplant 1992; 6: 77.
36. Vivas CA, Gritsch A, Shapiro R, et al. Cadaveric renal transplantation using donors over 60 years old: 5 year followup. Transplant Proc (in press).